People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other, Other Health Care, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| C3 Jian Inc | — | Other | Series C | $105.5M | $1.0B | 2009 |
| Merge Healthcare Inc | — | Other Health Care | Series C | $45.3M | $81.5M | 2010 |
| TuHURA Biosciences, Inc./NV | — | Biotechnology | Series B | $41.6M | $6.1M | 2013 |
| Cell Source, Inc. | — | Biotechnology | Series A | $13.9M | $113.9M | 2015 |
| Azora Therapeutics, Inc. | — | Pharmaceuticals | Series A | $8.3M | $4.5M | 2021 |
Dennis Brown at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dennis Brown on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yoram Drucker | 1 | 6 |
| Robert Hoffman | 1 | 5 |
| Keith Murphy | 1 | 4 |
| James Manuso | 1 | 4 |
| George Ng | 1 | 4 |
| James Bianco | 1 | 4 |
| Todd Patrick | 1 | 3 |
| Ben Friedman | 1 | 3 |
| Richard Bastiani | 1 | 3 |
| SAIID ZARRABIAN | 1 | 3 |
| H. Stewart Parker | 1 | 2 |
| Maxwell Anderson | 1 | 2 |
| Alan List | 1 | 2 |
| WILLIAM GARNER | 1 | 2 |
| Frederick Eichmiller | 1 | 2 |
| Matthew Davidson | 1 | 2 |
| John K. Bell | 1 | 2 |
| James Garrison | 1 | 2 |
| David Zolty | 1 | 2 |
| Jeffrey Bacha | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.